SPONSOR

Nanfang Hospital, Southern Medical University

Total Trials

Recruiting

Phases

N/A

Conditions studied: Swallowing-induced Pain Noncardiac Surgery Unruptured Intracranial Wide-neck Bifurcation Aneurysms Non-Cirrhotic Portal Hypertension Porto-Sinusoidal Vascular Diseases Sepsis Sepsis and Coagulopathy Chronic Kidney Diseases OSAS (Obstructive Sleep Apneas Syndrome)Flat Feet

Nanfang Hospital, Southern Medical University is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Swallowing-induced Pain, Noncardiac Surgery, Unruptured Intracranial Wide-neck Bifurcation Aneurysms, Non-Cirrhotic Portal Hypertension.

Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Nanfang Hospital, Southern Medical University

How many clinical trials has Nanfang Hospital, Southern Medical University sponsored?

ClinicalMetric currently tracks 15 clinical trials sponsored by Nanfang Hospital, Southern Medical University, of which 15 are actively recruiting participants. These trials cover conditions including Swallowing-induced Pain, Noncardiac Surgery, Unruptured Intracranial Wide-neck Bifurcation Aneurysms. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Nanfang Hospital, Southern Medical University research focus on?

Nanfang Hospital, Southern Medical University clinical trials span Swallowing-induced Pain, Noncardiac Surgery, Unruptured Intracranial Wide-neck Bifurcation Aneurysms, Non-Cirrhotic Portal Hypertension, Porto-Sinusoidal Vascular Diseases, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.

How do I participate in a Nanfang Hospital, Southern Medical University clinical trial?

To participate in a Nanfang Hospital, Southern Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nanfang Hospital, Southern Medical University trials with current recruitment status updated daily.

Nanfang Hospital, Southern Medical University

Frequently Asked Questions — Nanfang Hospital, Southern Medical University

Clinical Trials by Nanfang Hospital, Southern Medical University

Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma

Prediction of Vascular Events After Major Non-Cardiac Surgery : an Observational Prospective Cohort Study

Flow Diverter Versus Conventional Endovascular Treatment for Unruptured Wide-Neck Bifurcation Aneurysms (FD-BWA Trial)

Non-invasive Tools for PSVD Diagnosis

Sepsis-associated Thrombocytopenia and Platelet Transfusion （STAPT）

The Outcome of Chronic Kidney Disease Patients With Obstructive Sleep Apnea Syndrome

Plantar Stimulation, Whole-Body Vibration, and Baduanjin for Muscle Activation

Association of Inflammatory Factors With Complications in the Diabetic Population: a Cross-sectional Study

Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study

Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

Prospective, Multicenter, Randomized Controlled Phase III Trial of Biological Mesh for Alimentary Tract Reconstruction in Digestive Surgery

Novel Humanized Ferritin-Based NIR Fluorescent Probe for Identifying Sentinel Lymph Node Metastasis in Early Gastric Cancer

Prospective Pathology Foundation Models

Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer.

Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma